MVCC thINCubator, Clarkson, and Cornell awarded FuzeHub manufacturing grants

ALBANY, N.Y. — thINCubator in Utica, Clarkson University, and Cornell University are among seven nonprofits awarded manufacturing grants in this year’s second round of funding from FuzeHub. The Empire State Development-supported, manufacturing-grants program awarded $455,000 in grants to facilitate research and development, technical advancements, and process improvements for New York State manufacturers. Two applicants each from both the Finger Lakes and New York City regions were also among the grant recipients. FuzeHub is an Albany–based nonprofit that works to help New York State manufacturers and technology companies. FuzeHub offers manufacturing grants to New York State nonprofit organizations, including higher education institutions, that propose projects in partnership with a New York State small to medium-sized manufacturer. The funding comes through the Jeff Lawrence Innovation Fund, which has more than $1 million annually. It supports a set of activities designed to spur technology development and commercialization across New York State and is made possible through funding and support from Empire State Development’s Division of Science, Technology and Innovation (NYSTAR) and the U.S. Economic Development Administration (EDA). Regional grant recipients FuzeHub awarded $65,000 grants to each of the recipients. They include thINCubator (Mohawk Valley Community College Foundation) and Modovolo, Inc., which is working on the Modovolo Lift. The company describes the product as a “drone with amazing flight time; extremely low cost,” per the FuzeHub announcement. In addition, Clarkson University CAMP (Center for Advanced Materials Processing) is working with KLAW Industries LLC, which has operations in the North Country and Southern Tier. Clarkson University and KLAW Industries are partnering with FuzeHub to bring a new recycling technology leveraging artificial intelligence to market in the Southern Tier. Cornell University’s department of biomedical engineering is working with Anova Biomedical Inc. The FuzeHub announcement included their product description,”800,000 Americans undergo dialysis every year as treatment for kidney failure. Vascular access - the conduit through which blood is collected for dialysis - is referred to as the Achilles’ Heel of dialysis. Faulty vascular access causes hundreds of thousands of hospitalizations every year and accounts for billions of dollars of excess spending in our healthcare system. The “Anova graft” will be the first vascular access to harness the body’s healing potential to transform from a synthetic implant to a fully biological conduit to revolutionize dialysis access for millions of patients.”